1.
Akihiro Kitadate, Hiroki Kobayashi, Yoshiaki Abe, Kentaro Narita, Daisuke Miura, Masami Takeuchi, Kosei Matsue. Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients. haematol [Internet]. 2020Jan.1 [cited 2024Apr.15];105(1):e37-e40. Available from: https://haematologica.org/article/view/9503